BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)
CUSIP: 09075V102
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
- Shares outstanding
- 253,647,595
- Total 13F shares
- 47,893,570
- Share change
- -4,544,808
- Total reported value
- $4,559,340,245
- Put/Call ratio
- 108%
- Price per share
- $95.20
- Number of holders
- 283
- Value change
- -$440,516,031
- Number of buys
- 136
- Number of sells
- 111
Quarterly Holders Quick Answers
What is CUSIP 09075V102?
CUSIP 09075V102 identifies BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09075V102:
Top shareholders of BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Medine GmbH |
13D/G
|
Prof. Ugur Sahin, M.D. |
18%
|
42,178,034
|
$4,386,515,536 | $0 | 31 Mar 2025 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
3.1%
|
7,879,359
|
$777,062,385 | — | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
2.2%
|
5,453,480
|
$537,822,188 | — | 30 Sep 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.9%
|
4,833,642
|
$476,694,000 | — | 30 Sep 2025 | |
| Se Flossbach von Storch |
13F
|
Individual |
1.7%
|
4,230,033
|
$417,165,854 | — | 30 Sep 2025 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
1.5%
|
3,870,766
|
$381,734,943 | — | 30 Sep 2025 | |
| DODGE & COX |
13F
|
Company |
1.4%
|
3,647,091
|
$359,676,114 | — | 30 Sep 2025 | |
| PFIZER INC |
13F
|
Company |
0.65%
|
1,658,361
|
$163,547,562 | — | 30 Sep 2025 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.59%
|
1,506,027
|
$148,524,383 | — | 30 Sep 2025 | |
| Capital International Investors |
13F
|
Company |
0.45%
|
1,135,066
|
$111,940,209 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.43%
|
1,103,298
|
$108,807,249 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.3%
|
765,309
|
$75,474,736 | — | 30 Sep 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.29%
|
732,816
|
$72,270,267 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.24%
|
607,440
|
$59,905,733 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.24%
|
603,016
|
$59,469,525 | — | 30 Sep 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.23%
|
589,452
|
$58,131,756 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.23%
|
573,356
|
$56,544,369 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
568,707
|
$56,085,873 | — | 30 Sep 2025 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.19%
|
481,397
|
$47,230,000 | — | 30 Sep 2025 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.18%
|
459,673
|
$45,301,241 | — | 30 Sep 2025 | |
| Long Focus Capital Management, LLC |
13F
|
Company |
0.16%
|
397,655
|
$39,216,736 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.15%
|
389,495
|
$38,411,997 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.15%
|
382,476
|
$37,719,784 | — | 30 Sep 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.16%
|
413,685
|
$37,530,850 | — | 30 Sep 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.15%
|
368,923
|
$36,383,186 | — | 30 Sep 2025 | |
| LBP AM SA |
13F
|
Company |
0.14%
|
353,329
|
$34,845,306 | — | 30 Sep 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.12%
|
311,583
|
$30,702,371 | — | 30 Sep 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.12%
|
305,622
|
$30,140,441 | — | 30 Sep 2025 | |
| Capital International, Inc./CA/ |
13F
|
Company |
0.12%
|
293,208
|
$28,916,173 | — | 30 Sep 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.12%
|
291,907
|
$28,787,868 | — | 30 Sep 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.11%
|
270,000
|
$26,627,400 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
263,253
|
$25,962,011 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.1%
|
246,327
|
$24,292,769 | — | 30 Sep 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.09%
|
231,461
|
$22,827,000 | — | 30 Sep 2025 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.08%
|
210,777
|
$20,786,828 | — | 30 Sep 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.08%
|
205,004
|
$20,217,494 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.08%
|
197,018
|
$19,429,916 | — | 30 Sep 2025 | |
| Asset Managment Groupama |
13F
|
Individual |
0.08%
|
193,402
|
$19,073,305 | — | 30 Sep 2025 | |
| CenterBook Partners LP |
13F
|
Company |
0.07%
|
185,491
|
$18,293,122 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.07%
|
179,633
|
$17,715,406 | — | 30 Sep 2025 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.07%
|
168,871
|
$16,654,009 | — | 30 Sep 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.07%
|
168,041
|
$16,559,066 | — | 30 Sep 2025 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.06%
|
154,186
|
$15,205,823 | — | 30 Sep 2025 | |
| Baader Bank Aktiengesellschaft |
13F
|
Company |
0.06%
|
152,870
|
$14,927,641 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
146,584
|
$14,456,114 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.05%
|
126,635
|
$12,488,744 | — | 30 Sep 2025 | |
| Ghisallo Capital Management LLC |
13F
|
Company |
0.05%
|
125,000
|
$12,327,500 | — | 30 Sep 2025 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.05%
|
120,966
|
$11,929,667 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
115,990
|
$11,438,933 | — | 30 Sep 2025 | |
| VAN ECK ASSOCIATES CORP |
13F
|
Company |
0.04%
|
112,460
|
$11,090,000 | — | 30 Sep 2025 |
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q4 2025
As of 31 Dec 2025,
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by
283 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,893,570 shares.
The largest 10 holders included
FMR LLC, T. Rowe Price Investment Management, Inc., FLOSSBACH VON STORCH SE, PRIMECAP MANAGEMENT CO/CA/, Dodge & Cox, BNP PARIBAS FINANCIAL MARKETS, Temasek Holdings (Private) Ltd, JANE STREET GROUP, LLC, BAILLIE GIFFORD & CO, and BlackRock, Inc..
This page lists
283
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
253
Q4 2025 holders
283
Holder diff
30
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.